Shattuck Labs, Inc.

STTK ·Healthcare, Drug Manufacturers - General, United States
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Assets
Cash & Equivalents $54.2M $57.4M $125.6M $47.4M $92.3M $157.9M $7.0M
Accounts Receivable — — — — — — —
Inventory — — — — — — —
Total Current Assets $82.5M $79.2M $143.2M $184.6M $288.3M $345.6M $42.4M
Property, Plant & Equipment $6.1M $9.8M $13.8M $17.7M $9.9M $3.0M $2.4M
Goodwill — — — — — — —
Intangible Assets (Excl. Goodwill) — — — — — — —
Total Assets $91.0M $91.0M $159.6M $205.3M $298.6M $349.0M $45.0M
Liabilities
Accounts Payable $2.1M $2.4M $1.6M $7.2M $10.0M $1.8M $3.1M
Total Current Liabilities $7.1M $8.9M $11.5M $25.0M $24.6M $16.8M $20.0M
Long-Term Debt — — — — — — —
Total Liabilities $8.6M $11.4M $14.9M $29.2M $26.8M $39.1M $30.5M
Stockholders' Equity
Retained Earnings $-430.5M $-381.7M $-306.3M $-219.0M $-117.1M $-72.1M $-35.5M
Total Stockholders' Equity $82.4M $79.6M $144.7M $176.2M $271.8M $309.9M $-34.5M